Trials / Completed
CompletedNCT02217657
SmartTouch Catheter for Left Anterior Line - SmarT Line Study
"Bidirectional Conduction Block of Left Atrial Anterior Line in Patients With Left Atrial Ablation - Reduction of RF Applications Using the Thermocool SmartTouch Contact Force Sensing Catheter
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- LMU Klinikum · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, randomized study will investigate, if information of the catheter force during ablation of a left anterior line does reduce total RF application time by prevention of ineffective lesions.
Detailed description
Catheter ablation has emerged as a realistic therapeutic option for symptomatic atrial fibrillation (AF). The three main techniques described for ablation of persistent AF include pulmonary vein (PV) isolation, ablation based on electrogram analysis, and left atrial (LA) linear lesions. The ideal endpoint of linear lesions should be complete electrical block; however, this is technically challenging, time consuming, and potentially hazardous. The ST catheter combined with 3D mapping and navigation software, gives physicians a real-time, objective measure of tip-to-tissue contact force during the catheter ablation procedure and will allow physicians to more safely and effectively treat atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thermocool Smart Touch Catheter | Physician informed to contact force |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-08-15
- Last updated
- 2021-02-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02217657. Inclusion in this directory is not an endorsement.